New Jersey Business NJ

Bristol Myers Squibb sells controlling stake in first U.S.-China pharmaceutical joint venture

Return On Information New Jersey

Sep 16, 2025

After 43 years, Bristol Myers Squibb said it is ending the first U.S.-China pharmaceutical joint venture in China, according to a report from the website Fierce Pharma. BMS has agr…

Read the full story at Return On Information New Jersey

Topics

#China

Bristol Myers Squibb sells controlling stake in first U.S.-China pharmaceutical joint venture

Topics

More from New Jersey Business

Statement: Sherrill administration should have delayed New Jersey's new independent contractor regulations

New Report Says N.J. Needs More Affordable Homes for Sale, Not Just Buyer Assistance

100,000 Square Foot Expansion Breaks Ground at Liberty Science Center

Panoramic Manhattan Views and a Private Terrace Define This Avora Residence

New Jersey cannot afford to send mixed signals to business

Team Moza Debuts Casa One, Featuring 196 Rental Residences in Journal Square

Princeton Community Housing to Build Affordable Apartments on Former DPW Site

All-Affordable 113-Unit Development Moves Forward in Wayne